Lance Baldo - Mar 8, 2022 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Signature
/s/ Lance Baldo by Eric Billings, attorney-in-fact
Stock symbol
ADPT
Transactions as of
Mar 8, 2022
Transactions value $
-$38,291
Form type
4
Date filed
3/10/2022, 05:00 PM
Previous filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale -$38.3K -3.35K -16.32% $11.43 17.2K Mar 8, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
F2 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.28 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.